Protein Labelling Market By Product (Enzymes, Kits and Services), By Labeling Method (In-Vitro Labelling and In-vivo Labelling ), By Application (Cell-Based Assay, Mass Spectroscopy, Fluorescence Microscopy, Immunological Technique, and Protein Microarray), and By Region - Trends, Analysis and Forecast till 2030

Protein Labelling Market accounted for USD 1.89 Billion in 2020 and is estimated to be USD 4.69 Billion by 2030 and is anticipated to register a CAGR of 9.6%.

In biological research procedures, there is frequent utilization of molecular labels that are linked to a protein of interest in order to assist in the detection as well as purification of the labeled protein along with its binding partners. During the process of cell growth, proteins can be labeled by combination of amino acids comprising different isotopes or in biological fluids, cells, or tissue samples. The major applications for protein labeling include monitoring of biological processes, consistent quantification of compounds, detection of specific protein modifications as well as isoforms in multiplexed samples, improvement of detection sensitivity, and generalization of detection workflows. A large number of different types of protein labels are available. Their diverse uses are desirable for precise applications. Usually, three different types of tags are employed namely, stable isotopes, mass tags, and fluorophores. They help to target protein or sequence.

Increasing health care awareness, rising R&D expenditure, and increasing technological advancements and innovative products are driving growth of the protein labelling market. In addition, applications and services and development of proteomics coupled with the development of protein sequencing techniques are the other factors driving the protein labelling market. Factors such as rise in the incidence of chronic disorders such as cancer and increase in the need for their diagnosis are anticipated to boost demand for protein labelling techniques over the forecast period. For instance, the American Cancer Society, Inc. estimated that there will be around 1,735,350 new cancer cases diagnosed and 609,640 deaths owing to cancer in the U.S. in 2018. The reagents and kits that are used for the labeling of antibody or protein functional groups are expensive. Thus, due to this barrier, their use is restricted in some areas and alternatives are used for the diagnosis of chronic diseases, like cancer. These procedures are performed only by trained professionals.

However, due to the lack of skilled professionals, the growth of protein labeling market is constrained, thus acting as a major barrier. Moreover, computer-controlled systems for fluorescence and laser-confocal microscopy are also creating opportunity for the global market growth.

Protein labelling market is segmented based on product, labelling method, application, and region.

Based on product, the global protein labelling market is segmented into enzymes, kits and services. Based on the labelling method, the target market is segmented into in-vitro labelling and in-vivo labelling. Based on application, the target market is bifurcated into cell-based assay, mass spectroscopy, fluorescence microscopy, immunological technique, and protein microarray.

Regional Insights:

The protein labelling market accounted for US$ 1.89 billion in 2020 and is estimated to be US$ 4.69 billion by 2030 and is anticipated to register a CAGR of 9.6%. On region the protein labelling market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America accounts highest revenue share to the Protein Labelling market due to growing demand for advanced medical technologies and increasing geriatric population. Asia Pacific Protein Labelling market is projected to register a high CAGR over the forecast period owing to quick rise in acceptance of bioengineering technology solutions has also been seen in the region, which in turn is anticipated to drive their usage in the years to come.

Protein Labelling Market Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the protein labelling market report based on product, labelling method, application, and region.

Protein Labelling Market, By Region:

• North America
  • Middle East & Africa
    • • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • • U.S.
    • Canada

The key players operating the global Protein Labelling market involves SeraCare Life Sciences, Inc., Promega Corporation, F. Hoffmann-La Roche Ltd., Merck KgaA, Thermo Fisher Scientific, Inc., PerkinElmer, Inc., New England Biolabs, Eurogenetec S.A., Kaneka Corporation, and Kirkegaard & Perry Laboratories.

• SeraCare Life Sciences, Inc.
• Promega Corporation
• F. Hoffmann-La Roche Ltd.
• Merck KgaA
• Thermo Fisher Scientific, Inc.
• PerkinElmer, Inc.
• New England Biolabs
• Kaneka Corporation
• Eurogenetec S.A.
• Kirkegaard & Perry Laboratories.